Rizatriptan (Maxalt)
Also known as Maxalt
Rizatriptan (trade name Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).
Source: WikipediaDEA Class 5 meaning lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.
Estimated Total Cost: $261.83 for an average of 21 days supply
What is it prescribed for?
Patients are most commonly prescribed rizatriptan to treat migraine, headache, tension headache, and restless leg syndrome.
What drug interactions are known?
Critical Interactions
Significant Interactions
What side effects are related?
Patients taking rizatriptan most commonly experience side effects like nausea, weakness, and fatigue.
Loading...